The table below shows Cue Biopharma, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$10.94M
-$8.17M
-$9.78M
-$10.83M
-$11.57M
-$11.79M
Capital expenditure
$121.00K
$150.00K
$55.00K
$0.00
$27.00K
$648.00K
Investing cash flow
-$121.00K
-$150.00K
-$55.00K
$15.00M
-$27.00K
$9.35M
Dividends paid
-
-
-
CUE operating cash flow (10-K history)
Cue Biopharma, Inc. reported operating cash flow of -$21.69M for fiscal year 2025. That is up 40.3% from -$36.33M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$12.14M (FY 2017) to -$21.69M. Figures come from the company's audited annual reports as filed with the SEC.